Latest Press Releases Innate Pharma to participate in the D. Boral Capital Global Conference April 23, 2026 Innate Pharma to present MATISSE Phase 2 interim results of IPH5201 in Clinical Trials Plenary Session at AACR 2026 April 17, 2026 Innate Pharma to hold its annual general meeting of shareholders on May 21, 2026 April 13, 2026 Selected media Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
Innate Pharma to present MATISSE Phase 2 interim results of IPH5201 in Clinical Trials Plenary Session at AACR 2026 April 17, 2026
Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma
ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform
Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
